Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
83.716,18
-0,75%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Paratek Pharmaceuticals Inc (PRTK) Paratek Pharmaceuticals Inc (PRTK) Notizie

PRTK

Paratek Pharmaceuticals (PRTK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRTK
DataOraFonteTitoloSimboloCompagnia
05/10/202314:00GlobeNewswire Inc.Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023NASDAQ:PRTKParatek Pharmaceuticals Inc
02/10/202313:33Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:PRTKParatek Pharmaceuticals Inc
26/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202319:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202316:59Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202316:42Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202316:39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202315:10Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202315:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:58GlobeNewswire Inc.Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.NASDAQ:PRTKParatek Pharmaceuticals Inc
12/09/202323:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PRTKParatek Pharmaceuticals Inc
09/08/202320:37Business WireInvestor Alert: Abbott Cooper PLLC Announces Investigation into Paratek Pharmaceuticals, Inc.; Urges Paratek Stockholders to Contact Abbott Cooper Regarding Their Legal RightsNASDAQ:PRTKParatek Pharmaceuticals Inc
03/08/202314:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTKParatek Pharmaceuticals Inc
03/08/202314:00GlobeNewswire Inc.Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue of $40.0 MillionNASDAQ:PRTKParatek Pharmaceuticals Inc
02/08/202323:03Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:PRTKParatek Pharmaceuticals Inc
28/07/202318:55Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:PRTKParatek Pharmaceuticals Inc
11/07/202322:15PR Newswire (US)NexPoint Sends Demand Letter for Books and Records to Paratek Pharmaceuticals in Connection with Proposed Acquisition by Gurnet Point CapitalNASDAQ:PRTKParatek Pharmaceuticals Inc
10/07/202314:00GlobeNewswire Inc.Paratek Pharmaceuticals Announces Modification of BARDA Contract to Advance the Development of NUZYRA® (omadacycline) for Post-Exposure Prophylaxis (PEP) and Treatment of Pulmonary AnthraxNASDAQ:PRTKParatek Pharmaceuticals Inc
30/06/202316:38Edgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNASDAQ:PRTKParatek Pharmaceuticals Inc
30/06/202315:16Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:PRTKParatek Pharmaceuticals Inc
30/06/202315:16Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:PRTKParatek Pharmaceuticals Inc
27/06/202318:01GlobeNewswire Inc.Paratek Pharmaceuticals Acknowledges Receipt of NexPoint LetterNASDAQ:PRTKParatek Pharmaceuticals Inc
27/06/202314:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTKParatek Pharmaceuticals Inc
27/06/202314:00GlobeNewswire Inc.European Medicines Agency COMP Recommends Positive Opinion on Orphan Medicinal Product Designation for NUZYRA® (omadacycline) for Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:PRTKParatek Pharmaceuticals Inc
27/06/202314:00PR Newswire (US)NexPoint Asset Management Sends Open Letter to the Board of Paratek Pharmaceuticals Regarding Upcoming Annual Meeting and Proposed Acquisition by Gurnet Point CapitalNASDAQ:PRTKParatek Pharmaceuticals Inc
07/06/202312:12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PRTKParatek Pharmaceuticals Inc
07/06/202312:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTKParatek Pharmaceuticals Inc
07/06/202300:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:PRTKParatek Pharmaceuticals Inc
06/06/202315:59Dow Jones NewsParatek Pharmaceuticals to Be Acquired in Deal Worth Up to $462 MillionNASDAQ:PRTKParatek Pharmaceuticals Inc
09/05/202322:57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PRTKParatek Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRTK

La tua Cronologia

NYSE
MSGS
Madison Square Garden Sp...
BOV
BSCZ39
iShares MSCI EAFE SmallC...
KUCN
MTSUSDT
Metastrike
AMEX
DFNL
Davis Select Financial
LSE
FPM
Faroe Petroleum
COIN
CRUBTC
CRUST
NASDAQ
ABNBZXX
Morgan Stanley Bank Na C...
LATK
MCOETH
Crypto.com
USOTC
LKREF
Link Real Estate Investm... (PK)
NASDAQ
ABNIPXX
Morgan Stanley Issuer Ca...
AMEX
SCHP
Schwab US TIPs
EU
FER
Ferrovial
USOTC
PMMTF
Precious Metals and Mini... (PK)
KUCN
GNSUSDT
Gains Network
USOTC
KRMCF
KRM22 (PK)
NASDAQ
ABMQZXX
Morgan Stanley Finance L...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci